26th Apr 2021 13:54
(Alliance News) - EU legal action taken against AstraZeneca PLC over shortfalls in its delivery of Covid vaccines is "without merit", the drugs giant said Monday.
"We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible," the company said in a statement after the European Commission launched proceedings.
Shares in the company were 0.1% higher at 7,572.00 pence each in London on Monday afternoon.
source: AFP
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Astrazeneca